We are live on ! Find out more
OM icon

Outset Medical

152 hedge funds and large institutions have $1.26B invested in Outset Medical in 2022 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,263% more call options, than puts

Call options by funds: $9.99M | Put options by funds: $297K

67% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 24

66% more capital invested

Capital invested by funds: $760M → $1.26B (+$503M)

10% more funds holding

Funds holding: 138152 (+14)

0.14% more ownership

Funds ownership: 6.63%6.77% (+0.14%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 44

Holders
152
Holders Change
+14
Holders Change %
+10.14%
% of All Funds
2.44%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
40
Increased
44
Reduced
44
Closed
24
Calls
$9.99M
Puts
$297K
Net Calls
+$9.69M
Net Calls Change
+$11.3M
Name Holding Trade Value Shares
Change
Change in
Stake
Stifel Financial
76
Stifel Financial
Missouri
$637K -$25.4K -90 -5%
AIG
77
American International Group
New York
$592K +$3.1K +11 +0.7%
Mirae Asset Global Investments
78
Mirae Asset Global Investments
South Korea
$521K
BCI
79
Brinker Capital Investments
Pennsylvania
$504K -$6.49K -23 -2%
3F
80
360 Financial
Minnesota
$489K
Manulife (Manufacturers Life Insurance)
81
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$487K -$564 -2 -0.2%
State Board of Administration of Florida Retirement System
82
State Board of Administration of Florida Retirement System
Florida
$487K -$25.4K -90 -7%
Legal & General Group
83
Legal & General Group
United Kingdom
$476K +$10.2K +36 +3%
VOYA Investment Management
84
VOYA Investment Management
Georgia
$475K
GCM
85
Graham Capital Management
Connecticut
$424K +$309K +1,094 New
SB
86
Strategic Blueprint
Georgia
$407K +$296K +1,051 New
National Bank of Canada
87
National Bank of Canada
Quebec, Canada
$406K -$93.9K -333 -24%
BCM
88
Bayesian Capital Management
New York
$390K +$8.74K +31 +3%
APP
89
Alpha Paradigm Partners
Illinois
$374K +$272K +966 New
Federated Hermes
90
Federated Hermes
Pennsylvania
$361K
AGM
91
Alpine Global Management
New York
$301K +$219K +776 New
PIM
92
Perpetual Investment Management
Australia
$298K
ASRS
93
Arizona State Retirement System
Arizona
$297K +$9.02K +32 +4%
LBA
94
Letko, Brosseau & Associates
Quebec, Canada
$293K -$210K -743 -50%
Envestnet Asset Management
95
Envestnet Asset Management
Illinois
$288K -$39.5K -140 -16%
LOAME
96
Lombard Odier Asset Management (Europe)
United Kingdom
$284K +$207K +733 New
DT
97
Diversified Trust
Tennessee
$284K -$12.4K -44 -6%
Millennium Management
98
Millennium Management
New York
$281K -$150K -532 -42%
Cerity Partners
99
Cerity Partners
New York
$280K -$1.97K -7 -1%
CGH
100
Crossmark Global Holdings
Texas
$270K +$196K +696 New

OM Hedge Fund Activity: Q4 2022 in Review

152 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q4 2022, worth a combined $1.26B — up 66% from $760M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new OM positions and 24 closed out — a net gain of 16 holders — while 44 added to existing stakes and 44 trimmed.

The largest buyer was Barclays, adding an estimated $8.27M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $11.6M sold.

  • 152 institutional investors held Outset Medical (OM) as of Q4 2022, up from 138 in Q3 2022.
  • Funds reported $1.26B of Outset Medical stock for Q4 2022, up 66% quarter-over-quarter.
  • 40 funds opened new Outset Medical positions in Q4 2022 and 24 closed out, a net change of +16 holders.
  • The largest Outset Medical buyer in Q4 2022 was Barclays, an estimated $8.27M added.
  • The largest Outset Medical seller in Q4 2022 was PFM Health Sciences, an estimated $11.6M sold.

Based on aggregated 13F filings for Q4 2022.